Federal Policies and Prescription Drugs

Federal Policies and Prescription Drugs

This dissertation comprises three discrete empirical papers, with an introductory essay that evaluates the impact of different federal policies on prescription drug prices, utilization, and spending. Two main databases are used: (a) Medicaid State Drug Utilization Data and (b) the Medical Expenditur...

Full description

Bibliographic Details
Main Author:	Bonakdar Tehrani, Ali
Format:	Others
Published:	VCU Scholars Compass 2016
Subjects:	Medicare Doughnut Hole Medicaid Rebate Cancer Disparities Prescription Drug Price Health Services Research
Online Access:	http://scholarscompass.vcu.edu/etd/4144 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=5226&context=etd

Similar Items

CMS releases data on drug spending
by: Robbins RA
Published: (2016-11-01)

Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
by: Ilinca D. Metes, et al.
Published: (2019-10-01)

Impact of Medicare Part D coverage gap on beneficiaries' adherence to prescription medications
by: Desai, Urvi
Published: (2011)

Insurance status impacts treatment for hepatocellular carcinoma
by: Lindsay A. Sobotka, et al.
Published: (2019-05-01)

The Limited English Proficient Population: Describing Medicare, Medicaid, and Dual Beneficiaries
by: Kimberly Proctor, et al.
Published: (2018-05-01)

THE NEW MEDICARE PRESCRIPTION DRUG COVERAGE: HOW WELL DO SENIORS UNDERSTAND THE PROGRAM?
by: Linscott, Abbe Elaine
Published: (2006)

A patient-perspective approach to Medicare Part D prescription drug plan costs
by: Walberg, Mark P.
Published: (2009)

Medicaid Savings Continue in the year After end of Participation in the Program, Money Follows the Person
by: Glenn Landers, et al.
Published: (2017-07-01)

The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology
by: Charles E. Leonard, et al.
Published: (2017-04-01)

CMS rule would kick “problematic” doctors out of Medicare/Medicaid
by: Robbins RA
Published: (2019-11-01)

Market Discontinuation of Pharmaceuticals in the United States
by: Qureshi, Zaina Parvez
Published: (2009)

Drug ingredient acquisition cost determination for third-party prescription drug programs /
by: Wadelin, Jeffrey W.
Published: (1986)

Healthcare cost associations of patients who use illicit drugs in Florida: a retrospective analysis
by: Jessica L. Ryan, et al.
Published: (2020-09-01)

Should we do more to police medicaid fraud? Evidence on the intended and unintended consequences of expanded enforcement
by: Perez, V.
Published: (2019)

International reference pricing for prescription drugs: A landscape analysis
by: Kesselheim, A.S, et al.
Published: (2021)

Early evidence from South Carolina’s Medicare-Medicaid dual-eligible financial alignment initiative: an observational study to understand who enrolled, and whether the program improved health?
by: Brian K. Chen, et al.
Published: (2018-11-01)

Many southwest hosptials will receive decreased CMS reimbursement
by: Robbins RA
Published: (2013-11-01)

Adding a prescription drug benefit to Medicare: an analysis of the Medicare Prescription Drug, improvement, and modernization act of 2003
by: Jones, Carla D.
Published: (2012)

Organizing Care: U.S. Health Policy, Social Inequality, and the Work of Cancer Treatment
by: Armin, Julie
Published: (2015)

An examination of the effect of pharmacy operating characteristics, drug classification and method of payment on the gross margins of prescription drugs /
by: Gagnon, Jean Paul
Published: (1971)

An analysis of the effect of managed care implementation of prescription drug utilization by Texas Medicaid clients
by: Richards, Erika Kristin McKeithan
Published: (2011)

How the number of options and perceived variety influence choice satisfaction: An experiment with prescription drug plans
by: Helena Szrek
Published: (2017-01-01)

Impact of non-medical switching of prescription medications on health outcomes: an e-survey of high-volume medicare and medicaid physician providers
by: Craig Coleman, et al.
Published: (2020-01-01)

Improving drug prescription in general practice using a novel quality improvement model
by: Nicolas M. F. Øyane, et al.
Published: (2021-04-01)

The Effectiveness of State Policy in Combating Prescription Drug Abuse and Overdose
by: Hall, Madeline
Published: (2014)

Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?
by: Rena M. Conti, et al.
Published: (2018-11-01)

Reform Has Only Just Begun
by: Nick Turkal
Published: (2016-08-01)

Nursing Outcomes Classification: a cross-link to assign nursing home recertification survey severity scores
by: Cook, Elaine K.
Published: (2012)

Impact of US industry payment disclosure laws on payments to surgeons: a natural experiment
by: Taeho Greg Rhee, et al.
Published: (2020-01-01)

Burden of Clostridium difficile-associated disease among patients residing in nursing homes: a population-based cohort study
by: Holly Yu, et al.
Published: (2016-11-01)

Association of health insurance status with presentation, treatment and outcomes in soft tissue sarcoma
by: Varsha Jain, et al.
Published: (2019-10-01)

Strategies in Mitigating Medicare/Medicaid Fraud Risk
by: Adomako, Godfred
Published: (2017)

Integrated Marketing Communications: Branding Plan for Medicare y Mucho Mas
by: Camano, Javier
Published: (2006)

Disparities in health insurance coverage among children and young adults in Georgia and the U.S.
by: Brandon Attell
Published: (2016-07-01)

The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
by: Natalie Carvalho, et al.
Published: (2019-04-01)

Variations in prescription drug monitoring program use by prescriber specialty
by: Charlesworth, C.J, et al.
Published: (2018)

Analysis of medical prescriptions dispensed at health centers in Belo Horizonte, Minas Gerais, Brazil
by: Francisco A. Acurcio, et al.

Analysis of medical prescriptions dispensed at health centers in Belo Horizonte, Minas Gerais, Brazil
by: Acurcio Francisco A., et al.
Published: (2004-01-01)

Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?
by: Melinda M. Davis, et al.
Published: (2019-01-01)

Prescription Drug Monitoring Programs: A Policy Review and Recommendations for States
by: Lee, Christine Sh-Teng
Published: (2015)